|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Accrued severance pay, net | |||||
| Amortization of premium, discount and accrued interest on marketable securities | |||||
| Deferred taxes, net | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables, net | |||||
| Prepaid expenses and other current assets | |||||
| Trade payables | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease right-of-use assets | |||||
| Deferred revenue | |||||
| Realized (gain) loss on marketable securities, net | |||||
| Operating lease liabilities | |||||
| Amortization of discount on debt | |||||
| Loss from extinguishment of debt | |||||
| Change in fair value of contingent consideration | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Purchase of investments | |||||
| Proceeds from investments | |||||
| Proceeds from sales of marketable investments | |||||
| Proceeds from maturities of marketable investments | |||||
| Total proceeds from investments | |||||
| Payments for business acquisitions, net of cash acquired | |||||
| Capitalization of internal use software costs | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of shares upon exercise of options | |||||
| Purchase of treasury shares | |||||
| Dividends paid to non-controlling interest | |||||
| Purchase of subsidiaries shares from non-controlling interest | |||||
| Repayment of debt | |||||
| Proceeds from settlement of debt hedge option | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the year | |||||
| Cash, cash equivalents and restricted cash at the end of the year | |||||
| Cash paid during the year for: | |||||
| Income taxes | |||||
| Federal income taxes paid, net in the US | |||||
| United States | |||||
| Israel | |||||
| State income taxes paid, net in the US | |||||
| Income taxes paid, net in other jurisdictions | |||||
| Interest | |||||
| Non-cash activities: | |||||
| Change in fair value of contingent consideration | |||||
| Increase in accrued expenses and other liabilities with respect to purchase of treasury shares | |||||
| Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheet: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other current assets | |||||
Loading...